Bio-Rad Laboratories Inc

22 de ago. de 2026, 00:02 UTC

Bio Rad Laboratories Inc shares are higher in after-market hours, reflecting a broader market rebound amid gains in major stocks like Tesla and UnitedHealth.

21 de ago. de 2026, 23:21 UTC

Bio Rad Laboratories Inc shares are higher in after-market trading, influenced by Waters Corp's notable increase. Trading remains routine, with Bio Rad above its 20-day moving average.

20 de ago. de 2026, 23:41 UTC

Bio Rad Laboratories Inc shares are higher in after-market trading, recovering from an earlier dip. Declining jobless claims may support broader market sentiment.

19 de ago. de 2026, 20:03 UTC

Shares higher on strength in Life Sciences Tools & Services sector.

18 de ago. de 2026, 20:06 UTC

Bio Rad Laboratories Inc. is lower today, marking four consecutive daily declines. Rising U.S. Treasury yields amid inflation concerns contribute to the broader market context.

14 de ago. de 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, influenced by disappointing U.S. retail sales data that raised concerns about consumer demand and economic performance.

13 de ago. de 2026, 19:31 UTC

Bio Rad Laboratories Inc shares are declining today, influenced by significant downward movement in the Life Sciences Tools & Services sub-sector.

11 de ago. de 2026, 20:02 UTC

Bio Rad Laboratories Inc is trading higher, maintaining momentum after three consecutive gains. The price remains well above its 20-day moving average.

10 de ago. de 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, despite earlier gains. No specific news has been identified to explain the decline.

7 de ago. de 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

6 de ago. de 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are lower today, breaking a recent trend of gains. No specific news was identified to explain this decline.

5 de ago. de 2026, 20:03 UTC

Bio Rad Laboratories shares are higher as RBC raises its price target to $370. Wells Fargo and Citigroup also updated their price targets to $330.

4 de ago. de 2026, 22:02 UTC

Bio-Rad Laboratories shares are lower in after-market trading following a restructuring announcement and lowered full-year sales guidance despite strong second-quarter earnings.

3 de ago. de 2026, 19:46 UTC

Bio Rad Laboratories Inc is trading higher, supported by broader market trends amid falling oil prices. The stock remains near the upper end of its one-month range.

30 de jul. de 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29 de jul. de 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28 de jul. de 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27 de jul. de 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24 de jul. de 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23 de jul. de 2026, 20:03 UTC

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22 de jul. de 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21 de jul. de 2026, 16:26 UTC

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20 de jul. de 2026, 19:17 UTC

BIO shares lower; iShares U.S. Healthcare ETF declines during session.